{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T19:56:06Z","timestamp":1785527766802,"version":"3.56.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-026-04132-5","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:56:11Z","timestamp":1785286571000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Radiation retinopathy: a review"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8752-919X","authenticated-orcid":false,"given":"Ali","family":"Khodor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5365-8461","authenticated-orcid":false,"given":"Maria F.","family":"Colorado-Zavala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7022-2395","authenticated-orcid":false,"given":"Raul E.","family":"Ruiz-Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5237-240X","authenticated-orcid":false,"given":"Manuel E.","family":"Quiroga-Garza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1105-2848","authenticated-orcid":false,"given":"Eugenia M.","family":"Ramos-D\u00e1vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pachely","family":"Mendivil-Aguayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Symon","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7500-0731","authenticated-orcid":false,"given":"Amr","family":"Almobayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chima","family":"Orameh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpa J.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"issue":"4","key":"4132_CR1","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1097\/iae.0000000000003359","volume":"42","author":"R Parrozzani","year":"2022","unstructured":"Parrozzani R, Midena G, Frizziero L, Marchione G, Midena E (2022) Radiation maculopathy is anticipated by OCT hyperreflective retinal foci: a large, prospective, confirmation study. Retina 42(4):752\u2013759. https:\/\/doi.org\/10.1097\/iae.0000000000003359","journal-title":"Retina"},{"issue":"7","key":"4132_CR2","doi-asserted-by":"publisher","first-page":"6374","DOI":"10.3390\/curroncol30070470","volume":"30","author":"L Banou","year":"2023","unstructured":"Banou L, Tsani Z, Arvanitogiannis K, Pavlaki M, Dastiridou A, Androudi S (2023) Radiotherapy in uveal melanoma: a review of ocular complications. Curr Oncol 30(7):6374\u20136396. https:\/\/doi.org\/10.3390\/curroncol30070470","journal-title":"Curr Oncol"},{"issue":"4","key":"4132_CR3","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1080\/08820538.2021.2000623","volume":"37","author":"N Garcia-O\u2019Farrill","year":"2022","unstructured":"Garcia-O\u2019Farrill N, Pugazhendhi S, Karth PA, Hunter AA (2022) Radiation retinopathy intricacies and advances in management. Semin Ophthalmol 37(4):417\u2013435. https:\/\/doi.org\/10.1080\/08820538.2021.2000623","journal-title":"Semin Ophthalmol"},{"issue":"5","key":"4132_CR4","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/s41433-022-02200-5","volume":"37","author":"BE Powell","year":"2023","unstructured":"Powell BE, Chin KJ, Finger PT (2023) Early anti-VEGF treatment for radiation maculopathy and optic neuropathy: lessons learned. Eye (Lond) 37(5):866\u2013874. https:\/\/doi.org\/10.1038\/s41433-022-02200-5","journal-title":"Eye (Lond)"},{"issue":"7","key":"4132_CR5","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1001\/archopht.119.7.969","volume":"119","author":"M Diener-West","year":"2001","unstructured":"Diener-West M, Earle JD, Fine SL et al (2001) The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18. Arch Ophthalmol 119(7):969\u2013982. https:\/\/doi.org\/10.1001\/archopht.119.7.969","journal-title":"Arch Ophthalmol"},{"key":"4132_CR6","first-page":"T2","volume":"114","author":"IK Kim","year":"2016","unstructured":"Kim IK, Lane AM, Jain P, Awh C, Gragoudas ES (2016) Ranibizumab for the prevention of radiation complications in patients treated with proton beam irradiation for choroidal melanoma. Trans Am Ophthalmol Soc 114:T2","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"9","key":"4132_CR7","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1001\/archopht.118.9.1219","volume":"118","author":"CL Shields","year":"2000","unstructured":"Shields CL, Shields JA, Cater J et al (2000) Plaque radiotherapy for uveal melanoma: long-term visual outcome in 1106 consecutive patients. Arch Ophthalmol 118(9):1219\u20131228. https:\/\/doi.org\/10.1001\/archopht.118.9.1219","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"4132_CR8","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.survophthal.2020.08.007","volume":"66","author":"M Fallico","year":"2021","unstructured":"Fallico M, Chronopoulos A, Schutz JS, Reibaldi M (2021) Treatment of radiation maculopathy and radiation-induced macular edema: a systematic review. Surv Ophthalmol 66(3):441\u2013460. https:\/\/doi.org\/10.1016\/j.survophthal.2020.08.007","journal-title":"Surv Ophthalmol"},{"issue":"9","key":"4132_CR9","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1007\/s00417-016-3429-4","volume":"254","author":"I Seibel","year":"2016","unstructured":"Seibel I, Cordini D, Hager A et al (2016) Predictive risk factors for radiation retinopathy and optic neuropathy after proton beam therapy for uveal melanoma. Graefes Arch Clin Exp Ophthalmol 254(9):1787\u20131792. https:\/\/doi.org\/10.1007\/s00417-016-3429-4","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"4132_CR10","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.brachy.2018.07.002","volume":"17","author":"BHA Le","year":"2018","unstructured":"Le BHA, Kim JW, Deng H et al (2018) Outcomes of choroidal melanomas treated with eye physics plaques: a 25\u00a0year review. Brachytherapy 17(6):981\u2013989. https:\/\/doi.org\/10.1016\/j.brachy.2018.07.002","journal-title":"Brachytherapy"},{"issue":"8","key":"4132_CR11","doi-asserted-by":"publisher","first-page":"e1458","DOI":"10.1111\/aos.14814","volume":"99","author":"MV Cicinelli","year":"2021","unstructured":"Cicinelli MV, Di Nicola M, Gigliotti CR et al (2021) Predictive factors of radio-induced complications in 194 eyes undergoing gamma knife radiosurgery for uveal melanoma. Acta Ophthalmol 99(8):e1458\u2013e1466. https:\/\/doi.org\/10.1111\/aos.14814","journal-title":"Acta Ophthalmol"},{"issue":"Pt 2","key":"4132_CR12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/eye.1991.39","volume":"5","author":"DB Archer","year":"1991","unstructured":"Archer DB, Amoaku WM, Gardiner TA (1991) Radiation retinopathy\u2013clinical, histopathological, ultrastructural and experimental correlations. Eye (Lond) 5(Pt 2):239\u2013251. https:\/\/doi.org\/10.1038\/eye.1991.39","journal-title":"Eye (Lond)"},{"issue":"3","key":"4132_CR13","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/00006982-198700730-00004","volume":"7","author":"GT Boozalis","year":"1987","unstructured":"Boozalis GT, Schachat AP, Green WR (1987) Subretinal neovascularization from the retina in radiation retinopathy. Retina Fall 7(3):156\u2013161. https:\/\/doi.org\/10.1097\/00006982-198700730-00004","journal-title":"Retina Fall"},{"key":"4132_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21010211","author":"A Naylor","year":"2019","unstructured":"Naylor A, Hopkins A, Hudson N, Campbell M (2019) Tight junctions of the outer blood retina barrier. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21010211","journal-title":"Int J Mol Sci"},{"key":"4132_CR15","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/190724","author":"R Simo","year":"2010","unstructured":"Simo R, Villarroel M, Corraliza L, Hernandez C, Garcia-Ramirez M (2010) The retinal pigment epithelium: something more than a constituent of the blood-retinal barrier--implications for the pathogenesis of diabetic retinopathy. J Biomed Biotechnol. https:\/\/doi.org\/10.1155\/2010\/190724","journal-title":"J Biomed Biotechnol"},{"key":"4132_CR16","doi-asserted-by":"publisher","first-page":"109729","DOI":"10.1016\/j.exer.2023.109729","volume":"238","author":"E Liu","year":"2024","unstructured":"Liu E, Tamplin MR, Rosius J et al (2024) Mouse model of radiation retinopathy reveals vascular and neuronal injury. Exp Eye Res 238:109729. https:\/\/doi.org\/10.1016\/j.exer.2023.109729","journal-title":"Exp Eye Res"},{"issue":"1","key":"4132_CR17","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1186\/s12886-021-02140-w","volume":"21","author":"A Torkashvand","year":"2021","unstructured":"Torkashvand A, Riazi-Esfahani H, Ghassemi F et al (2021) Evaluation of radiation maculopathy after treatment of choroidal melanoma with ruthenium-106 using optical coherence tomography angiography. BMC Ophthalmol 21(1):385. https:\/\/doi.org\/10.1186\/s12886-021-02140-w","journal-title":"BMC Ophthalmol"},{"issue":"8","key":"4132_CR18","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1097\/IAE.0000000000001021","volume":"36","author":"CL Shields","year":"2016","unstructured":"Shields CL, Say EA, Samara WA, Khoo CT, Mashayekhi A, Shields JA (2016) Optical coherence tomography angiography of the macula after plaque radiotherapy of choroidal melanoma: comparison of irradiated versus nonirradiated eyes in 65 patients. Retina 36(8):1493\u20131505. https:\/\/doi.org\/10.1097\/IAE.0000000000001021","journal-title":"Retina"},{"issue":"1","key":"4132_CR19","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.1038\/s41598-024-53830-6","volume":"14","author":"MR Tamplin","year":"2024","unstructured":"Tamplin MR, Wang JK, Binkley EM et al (2024) Radiation effects on retinal layers revealed by OCT, OCT-A, and perimetry as a function of dose and time from treatment. Sci Rep 14(1):3380. https:\/\/doi.org\/10.1038\/s41598-024-53830-6","journal-title":"Sci Rep"},{"issue":"4","key":"4132_CR20","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.ajo.2009.11.006","volume":"149","author":"PT Finger","year":"2010","unstructured":"Finger PT, Chin KJ, Yu GP, Palladium-103 for Choroidal Melanoma Study G (2010) Risk factors for radiation maculopathy after ophthalmic plaque radiation for choroidal melanoma. Am J Ophthalmol 149(4):608\u2013615. https:\/\/doi.org\/10.1016\/j.ajo.2009.11.006","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"4132_CR21","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.ophtha.2009.10.015","volume":"117","author":"C Bianciotto","year":"2010","unstructured":"Bianciotto C, Shields CL, Pirondini C, Mashayekhi A, Furuta M, Shields JA (2010) Proliferative radiation retinopathy after plaque radiotherapy for uveal melanoma. Ophthalmology 117(5):1005\u20131012. https:\/\/doi.org\/10.1016\/j.ophtha.2009.10.015","journal-title":"Ophthalmology"},{"key":"4132_CR22","doi-asserted-by":"publisher","unstructured":"Gragoudas ES, Li W, Lane AM, Munzenrider J, Egan KM (1999) Risk factors for radiation maculopathy and papillopathy after intraocular irradiation. Ophthalmology. 106(8):1571\u20137; discussion 1577\u20138. https:\/\/doi.org\/10.1016\/S0161-6420(99)90455-4","DOI":"10.1016\/S0161-6420(99)90455-4"},{"issue":"12","key":"4132_CR23","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1016\/s0161-6420(82)34611-4","volume":"89","author":"GC Brown","year":"1982","unstructured":"Brown GC, Shields JA, Sanborn G, Augsburger JJ, Savino PJ, Schatz NJ (1982) Radiation retinopathy. Ophthalmology 89(12):1494\u20131501. https:\/\/doi.org\/10.1016\/s0161-6420(82)34611-4","journal-title":"Ophthalmology"},{"issue":"6","key":"4132_CR24","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/s0002-9394(14)77269-1","volume":"112","author":"PF Lopez","year":"1991","unstructured":"Lopez PF, Sternberg P Jr., Dabbs CK, Vogler WR, Crocker I, Kalin NS (1991) Bone marrow transplant retinopathy. Am J Ophthalmol 112(6):635\u2013646. https:\/\/doi.org\/10.1016\/s0002-9394(14)77269-1","journal-title":"Am J Ophthalmol"},{"issue":"Pt 1","key":"4132_CR25","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/eye.2000.28","volume":"14","author":"B Kumar","year":"2000","unstructured":"Kumar B, Palimar P (2000) Accelerated radiation retinopathy in diabetes and pregnancy. Eye (Lond) 14(Pt 1):107\u2013108. https:\/\/doi.org\/10.1038\/eye.2000.28","journal-title":"Eye (Lond)"},{"issue":"2","key":"4132_CR26","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/IAE.0b013e31814b1b75","volume":"28","author":"N Horgan","year":"2008","unstructured":"Horgan N, Shields CL, Mashayekhi A, Teixeira LF, Materin MA, Shields JA (2008) Early macular morphological changes following plaque radiotherapy for uveal melanoma. Retina 28(2):263\u2013273. https:\/\/doi.org\/10.1097\/IAE.0b013e31814b1b75","journal-title":"Retina"},{"issue":"5","key":"4132_CR27","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/s0002-9394(98)00445-0","volume":"127","author":"K Gunduz","year":"1999","unstructured":"Gunduz K, Shields CL, Shields JA, Cater J, Freire JE, Brady LW (1999) Radiation complications and tumor control after plaque radiotherapy of choroidal melanoma with macular involvement. Am J Ophthalmol 127(5):579\u2013589. https:\/\/doi.org\/10.1016\/s0002-9394(98)00445-0","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"4132_CR28","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/s0360-3016(99)00057-7","volume":"44","author":"A Takeda","year":"1999","unstructured":"Takeda A, Shigematsu N, Suzuki S et al (1999) Late retinal complications of radiation therapy for nasal and paranasal malignancies: relationship between irradiated-dose area and severity. Int J Radiat Oncol Biol Phys 44(3):599\u2013605. https:\/\/doi.org\/10.1016\/s0360-3016(99)00057-7","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"4132_CR29","doi-asserted-by":"publisher","first-page":"e169","DOI":"10.1016\/j.prro.2014.09.005","volume":"5","author":"V Takiar","year":"2015","unstructured":"Takiar V, Voong KR, Gombos DS et al (2015) A choice of radionuclide: comparative outcomes and toxicity of ruthenium-106 and iodine-125 in the definitive treatment of uveal melanoma. Pract Radiat Oncol 5(3):e169\u2013e176. https:\/\/doi.org\/10.1016\/j.prro.2014.09.005","journal-title":"Pract Radiat Oncol"},{"issue":"4","key":"4132_CR30","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/0360-3016(94)90347-6","volume":"30","author":"JT Parsons","year":"1994","unstructured":"Parsons JT, Bova FJ, Fitzgerald CR, Mendenhall WM, Million RR (1994) Radiation retinopathy after external-beam irradiation: analysis of time-dose factors. Int J Radiat Oncol Biol Phys 30(4):765\u2013773. https:\/\/doi.org\/10.1016\/0360-3016(94)90347-6","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"4132_CR31","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.ijrobp.2004.07.664","volume":"61","author":"AT Monroe","year":"2005","unstructured":"Monroe AT, Bhandare N, Morris CG, Mendenhall WM (2005) Preventing radiation retinopathy with hyperfractionation. Int J Radiat Oncol Biol Phys 61(3):856\u2013864. https:\/\/doi.org\/10.1016\/j.ijrobp.2004.07.664","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4132_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9113496","author":"G Midena","year":"2020","unstructured":"Midena G, Parrozzani R, Frizziero L, Midena E (2020) Chorioretinal side effects of therapeutic ocular irradiation: a multimodal imaging approach. J Clin Med. https:\/\/doi.org\/10.3390\/jcm9113496","journal-title":"J Clin Med"},{"key":"4132_CR33","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ajo.2017.06.008","volume":"181","author":"A Sellam","year":"2017","unstructured":"Sellam A, Coscas F, Lumbroso-Le Rouic L et al (2017) Optical coherence tomography angiography of macular features after proton beam radiotherapy for small choroidal melanoma. Am J Ophthalmol 181:12\u201319. https:\/\/doi.org\/10.1016\/j.ajo.2017.06.008","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"4132_CR34","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/ICU.0b013e3283386687","volume":"21","author":"N Horgan","year":"2010","unstructured":"Horgan N, Shields CL, Mashayekhi A, Shields JA (2010) Classification and treatment of radiation maculopathy. Curr Opin Ophthalmol 21(3):233\u2013238. https:\/\/doi.org\/10.1097\/ICU.0b013e3283386687","journal-title":"Curr Opin Ophthalmol"},{"issue":"5","key":"4132_CR35","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3928\/23258160-20240129-01","volume":"55","author":"ST Corona","year":"2024","unstructured":"Corona ST, Ali OI, Yu HJ, Schefler AC, Group RRRS (2024) Morphological biomarkers related to visual acuity in patients with radiation retinopathy treated with intravitreal ranibizumab. Ophthalmic Surg Lasers Imaging Retina 55(5):255\u2013262. https:\/\/doi.org\/10.3928\/23258160-20240129-01","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"3","key":"4132_CR36","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41433-020-01237-8","volume":"35","author":"TE de Carlo","year":"2021","unstructured":"de Carlo TE, Mieler WF (2021) Automated quantitative OCTA measurements of uveal melanoma-treated eyes with and without radiation retinopathy after I-125 plaque therapy and of nonirradiated fellow eyes. Eye (Lond) 35(3):769\u2013776. https:\/\/doi.org\/10.1038\/s41433-020-01237-8","journal-title":"Eye (Lond)"},{"issue":"6","key":"4132_CR37","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1177\/2474126420936199","volume":"4","author":"KM Green","year":"2020","unstructured":"Green KM, Toy BC, Ashimatey BS et al (2020) Quantifying subclinical and longitudinal microvascular changes following episcleral plaque brachytherapy using spectral domain-optical coherence tomography angiography. J Vitreoretin Dis 4(6):499\u2013508. https:\/\/doi.org\/10.1177\/2474126420936199","journal-title":"J Vitreoretin Dis"},{"issue":"10","key":"4132_CR38","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1097\/IAE.0000000000003559","volume":"42","author":"C Gilli","year":"2022","unstructured":"Gilli C, Kodjikian L, Loria O et al (2022) Quantitative analysis of choriocapillaris alterations in swept-source optical coherence tomography-angiography during radiation retinopathy. Retina 42(10):1995\u20132003. https:\/\/doi.org\/10.1097\/IAE.0000000000003559","journal-title":"Retina"},{"issue":"3","key":"4132_CR39","first-page":"183","volume":"15","author":"M Li","year":"1999","unstructured":"Li M, Qiu G, Luo W, Ou J, Li X (1999) Clinical investigation of radiation retinopathy fundus and fluorescein angiographic features. Yan Ke Xue Bao 15(3):183\u2013186","journal-title":"Yan Ke Xue Bao"},{"key":"4132_CR40","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2174\/1874364101610010103","volume":"10","author":"AW Stacey","year":"2016","unstructured":"Stacey AW, Demirci H (2016) Serial intravitreal bevacizumab injections slow the progression of radiation maculopathy following Iodine-125 plaque radiotherapy. Open Ophthalmol J 10:103\u2013110. https:\/\/doi.org\/10.2174\/1874364101610010103","journal-title":"Open Ophthalmol J"},{"issue":"Pt 5","key":"4132_CR41","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/eye.1990.93","volume":"4","author":"WM Amoaku","year":"1990","unstructured":"Amoaku WM, Archer DB (1990) Fluorescein angiographic features, natural course and treatment of radiation retinopathy. Eye (Lond) 4(Pt 5):657\u2013667. https:\/\/doi.org\/10.1038\/eye.1990.93","journal-title":"Eye (Lond)"},{"issue":"12","key":"4132_CR42","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1097\/IAE.0000000000001874","volume":"38","author":"TA McCannel","year":"2018","unstructured":"McCannel TA, Kim E, Kamrava M et al (2018) New ultra-wide-field angiographic grading scheme for radiation retinopathy after Iodine-125 brachytherapy for uveal melanoma. Retina 38(12):2415\u20132421. https:\/\/doi.org\/10.1097\/IAE.0000000000001874","journal-title":"Retina"},{"issue":"3","key":"4132_CR43","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.ajo.2005.02.055","volume":"140","author":"A Manivannan","year":"2005","unstructured":"Manivannan A, Plskova J, Farrow A, McKay S, Sharp PF, Forrester JV (2005) Ultra-wide-field fluorescein angiography of the ocular fundus. Am J Ophthalmol 140(3):525\u2013527. https:\/\/doi.org\/10.1016\/j.ajo.2005.02.055","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"4132_CR44","doi-asserted-by":"publisher","first-page":"940","DOI":"10.4103\/0301-4738.198850","volume":"64","author":"C Jayadev","year":"2016","unstructured":"Jayadev C, Jain N, Sachdev S, Mohan A, Yadav NK (2016) Utility of noninvasive imaging modalities in a retina practice. Indian J Ophthalmol 64(12):940\u2013943. https:\/\/doi.org\/10.4103\/0301-4738.198850","journal-title":"Indian J Ophthalmol"},{"issue":"9","key":"4132_CR45","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1001\/archopht.1993.01090090015002","volume":"111","author":"S Yoneya","year":"1993","unstructured":"Yoneya S, Noyori K (1993) Improved visualization of the choroidal circulation with indocyanine green angiography. Arch Ophthalmol 111(9):1165\u20131166. https:\/\/doi.org\/10.1001\/archopht.1993.01090090015002","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"4132_CR46","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1177\/112067210601600426","volume":"16","author":"E Peiretti","year":"2006","unstructured":"Peiretti E, Slakter JS, Wu S, Iranmanesh R, Yannuzzi LA (2006) Late effect of external eye irradiation on choroidal circulation. Eur J Ophthalmol 16(4):637\u2013640. https:\/\/doi.org\/10.1177\/112067210601600426","journal-title":"Eur J Ophthalmol"},{"issue":"4","key":"4132_CR47","doi-asserted-by":"publisher","first-page":"148","DOI":"10.4103\/0301-4738.112159","volume":"61","author":"RV Agrawal","year":"2013","unstructured":"Agrawal RV, Biswas J, Gunasekaran D (2013) Indocyanine green angiography in posterior uveitis. Indian J Ophthalmol 61(4):148\u2013159. https:\/\/doi.org\/10.4103\/0301-4738.112159","journal-title":"Indian J Ophthalmol"},{"issue":"9","key":"4132_CR48","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1097\/IAE.0b013e3182618d43","volume":"32","author":"CP Herbort","year":"2012","unstructured":"Herbort CP, Neri P, El Asrar AA et al (2012) Is ICGA still relevant in inflammatory eye disorders? Why this question has to be dealt with separately from other eye conditions. Retina 32(9):1701\u20131703. https:\/\/doi.org\/10.1097\/IAE.0b013e3182618d43","journal-title":"Retina"},{"issue":"6","key":"4132_CR49","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1136\/bjo.2004.052159","volume":"89","author":"PT Finger","year":"2005","unstructured":"Finger PT, Kurli M (2005) Laser photocoagulation for radiation retinopathy after ophthalmic plaque radiation therapy. Br J Ophthalmol 89(6):730\u2013738. https:\/\/doi.org\/10.1136\/bjo.2004.052159","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"4132_CR50","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/ICU.0000000000000141","volume":"26","author":"D Reichstein","year":"2015","unstructured":"Reichstein D (2015) Current treatments and preventive strategies for radiation retinopathy. Curr Opin Ophthalmol 26(3):157\u2013166. https:\/\/doi.org\/10.1097\/ICU.0000000000000141","journal-title":"Curr Opin Ophthalmol"},{"issue":"5","key":"4132_CR51","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/0002-9394(88)90237-1","volume":"105","author":"JL Kinyoun","year":"1988","unstructured":"Kinyoun JL, Chittum ME, Wells CG (1988) Photocoagulation treatment of radiation retinopathy. Am J Ophthalmol 105(5):470\u2013478. https:\/\/doi.org\/10.1016\/0002-9394(88)90237-1","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"4132_CR52","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1001\/archopht.1996.01100140299007","volume":"114","author":"JL Kinyoun","year":"1996","unstructured":"Kinyoun JL, Lawrence BS, Barlow WE (1996) Proliferative radiation retinopathy. Arch Ophthalmol 114(9):1097\u20131100. https:\/\/doi.org\/10.1001\/archopht.1996.01100140299007","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"4132_CR53","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/08820538.2017.1353820","volume":"33","author":"SV Reddy","year":"2018","unstructured":"Reddy SV, Husain D (2018) Panretinal photocoagulation: a review of complications. Semin Ophthalmol 33(1):83\u201388. https:\/\/doi.org\/10.1080\/08820538.2017.1353820","journal-title":"Semin Ophthalmol"},{"key":"4132_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines6010017","author":"MA Blasi","year":"2018","unstructured":"Blasi MA, Pagliara MM, Lanza A et al (2018) Photodynamic therapy in ocular oncology. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines6010017","journal-title":"Biomedicines"},{"issue":"1","key":"4132_CR55","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3109\/0284186X.2010.500299","volume":"50","author":"GP Giuliari","year":"2011","unstructured":"Giuliari GP, Sadaka A, Hinkle DM, Simpson ER (2011) Current treatments for radiation retinopathy. Acta Oncol 50(1):6\u201313. https:\/\/doi.org\/10.3109\/0284186X.2010.500299","journal-title":"Acta Oncol"},{"issue":"6","key":"4132_CR56","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3928\/1542-8877-20031101-10","volume":"34","author":"SJ Bakri","year":"2003","unstructured":"Bakri SJ, Beer PM (2003) Photodynamic therapy with verteporfin for classic choroidal neovascularization secondary to focal laser photocoagulation for radiation retinopathy. Ophthalmic Surg Lasers Imaging 34(6):475\u2013477","journal-title":"Ophthalmic Surg Lasers Imaging"},{"issue":"7","key":"4132_CR57","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/sj.eye.6700736","volume":"18","author":"SC Lee","year":"2004","unstructured":"Lee SC, Song JH, Chung EJ, Kwon OW (2004) Photodynamic therapy of subretinal neovascularization in radiation retinopathy. Eye (Lond) 18(7):745\u2013746. https:\/\/doi.org\/10.1038\/sj.eye.6700736","journal-title":"Eye (Lond)"},{"issue":"3","key":"4132_CR58","first-page":"624","volume":"41","author":"NM Bressler","year":"2000","unstructured":"Bressler NM, Bressler SB (2000) Photodynamic therapy with verteporfin (Visudyne): impact on ophthalmology and visual sciences. Invest Ophthalmol Vis Sci 41(3):624\u2013628","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"4132_CR59","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.3928\/23258160-20200401-06","volume":"51","author":"N Rayess","year":"2020","unstructured":"Rayess N, Mruthyunjaya P (2020) Anti-vascular endothelial growth factor therapy for radiation retinopathy. Ophthalmic Surg Lasers Imaging Retina 51(4):S44\u2013S49. https:\/\/doi.org\/10.3928\/23258160-20200401-06","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"4132_CR60","doi-asserted-by":"publisher","unstructured":"Sanchez-Vicente JL, Munoz-Morales A, Galvan-Carrasco MP et al (2017) Radiation maculopathy treated with intravitreal bevacizumab. Arch Soc Esp Oftalmol. 92(6):283\u2013286. Bevacizumab intravitreo en el tratamiento de la maculopatia por radiacion. https:\/\/doi.org\/10.1016\/j.oftal.2016.10.008","DOI":"10.1016\/j.oftal.2016.10.008"},{"issue":"7","key":"4132_CR61","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1097\/IAE.0b013e31806e6042","volume":"27","author":"JO Mason 3rd","year":"2007","unstructured":"Mason JO 3rd, Albert MA Jr, Persaud TO, Vail RS (2007) Intravitreal bevacizumab treatment for radiation macular edema after plaque radiotherapy for choroidal melanoma. Retina 27(7):903\u2013907. https:\/\/doi.org\/10.1097\/IAE.0b013e31806e6042","journal-title":"Retina"},{"issue":"6","key":"4132_CR62","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1001\/archopht.125.6.751","volume":"125","author":"PT Finger","year":"2007","unstructured":"Finger PT, Chin K (2007) Anti-vascular endothelial growth factor bevacizumab (avastin) for radiation retinopathy. Arch Ophthalmol 125(6):751\u2013756. https:\/\/doi.org\/10.1001\/archopht.125.6.751","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"4132_CR63","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1097\/IAE.0b013e3181706302","volume":"28","author":"A Gupta","year":"2008","unstructured":"Gupta A, Muecke JS (2008) Treatment of radiation maculopathy with intravitreal injection of bevacizumab (Avastin). Retina 28(7):964\u2013968. https:\/\/doi.org\/10.1097\/IAE.0b013e3181706302","journal-title":"Retina"},{"issue":"1","key":"4132_CR64","doi-asserted-by":"publisher","first-page":"60","DOI":"10.5301\/ejo.5000670","volume":"26","author":"PT Finger","year":"2016","unstructured":"Finger PT, Chin KJ, Semenova EA (2016) Intravitreal anti-VEGF therapy for macular radiation retinopathy: a 10-year study. Eur J Ophthalmol 26(1):60\u201366. https:\/\/doi.org\/10.5301\/ejo.5000670","journal-title":"Eur J Ophthalmol"},{"issue":"8","key":"4132_CR65","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1097\/IAE.0000000000002200","volume":"39","author":"A Daruich","year":"2019","unstructured":"Daruich A, Matet A, Schalenbourg A, Zografos L (2019) Intravitreal anti-vascular endothelial growth factor treatment at 2-month intervals reduces foveal avascular zone enlargement and vision loss in radiation maculopathy: a pilot study. Retina 39(8):1519\u20131526. https:\/\/doi.org\/10.1097\/IAE.0000000000002200","journal-title":"Retina"},{"issue":"4","key":"4132_CR66","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1159\/000452163","volume":"3","author":"MA Khan","year":"2017","unstructured":"Khan MA, Mashayekhi A, Shields JA, Shields CL (2017) Intravitreal aflibercept as rescue therapy for post-radiation cystoid macular edema resistant to intravitreal bevacizumab: outcomes at 1\u00a0year. Ocul Oncol Pathol 3(4):313\u2013319. https:\/\/doi.org\/10.1159\/000452163","journal-title":"Ocul Oncol Pathol"},{"issue":"7","key":"4132_CR67","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1167\/iovs.64.7.35","volume":"64","author":"S Trejo Corona","year":"2023","unstructured":"Trejo Corona S, Villanueva Boone C, Ali AM et al (2023) Randomized trial of treat-and-extend intravitreal aflibercept for radiation retinopathy: 1-year outcomes. Invest Ophthalmol Vis Sci 64(7):35. https:\/\/doi.org\/10.1167\/iovs.64.7.35","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"4132_CR68","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.oret.2019.02.009","volume":"3","author":"TG Murray","year":"2019","unstructured":"Murray TG, Latiff A, Villegas VM, Gold AS (2019) Aflibercept for radiation maculopathy study: a prospective. Randomized Clinic Study Ophthalmol Retina 3(7):561\u2013566. https:\/\/doi.org\/10.1016\/j.oret.2019.02.009","journal-title":"Randomized Clinic Study Ophthalmol Retina"},{"key":"4132_CR69","unstructured":"A Trial Evaluating Intravitreal Faricimab (6.0 Mg) Injections or Fluocinolone Acetonide (0.19 Mg Intravitreal Implants Vs Observation for Prevention of Visual Acuity Loss Due to Radiation Retinopathy. National Library of Medicine (US). https:\/\/clinicaltrials.gov\/study\/NCT05844982"},{"issue":"1","key":"4132_CR70","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00417-021-05281-2","volume":"260","author":"HJ Yu","year":"2022","unstructured":"Yu HJ, Fuller D, Anand R et al (2022) Two-year results for ranibizumab for radiation retinopathy (RRR): a randomized, prospective trial. Graefes Arch Clin Exp Ophthalmol 260(1):47\u201354","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"5","key":"4132_CR71","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3928\/23258160-20240129-01","volume":"55","author":"ST Corona","year":"2024","unstructured":"Corona ST, Ali OI, Yu HJ, Schefler AC (2024) Morphological biomarkers related to visual acuity in patients with radiation retinopathy treated with intravitreal ranibizumab. Ophthalmic Surg Lasers Imaging Retina 55(5):255\u2013262","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"4132_CR72","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ajo.2016.04.024","volume":"168","author":"I Seibel","year":"2016","unstructured":"Seibel I, Hager A, Riechardt AI, Davids AM, Boker A, Joussen AM (2016) Antiangiogenic or corticosteroid treatment in patients with radiation maculopathy after proton beam therapy for uveal melanoma. Am J Ophthalmol 168:31\u201339. https:\/\/doi.org\/10.1016\/j.ajo.2016.04.024","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"4132_CR73","doi-asserted-by":"publisher","first-page":"e694","DOI":"10.1111\/aos.12424","volume":"92","author":"L Tarmann","year":"2014","unstructured":"Tarmann L, Langmann G, Mayer C, Weger M, Haas A, Wackernagel W (2014) Ozurdex((R)) reduces the retinal thickness in radiation maculopathy refractory to bevacizumab. Acta Ophthalmol 92(8):e694\u2013e696. https:\/\/doi.org\/10.1111\/aos.12424","journal-title":"Acta Ophthalmol"},{"issue":"7","key":"4132_CR74","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/j.ophtha.2009.01.051","volume":"116","author":"N Horgan","year":"2009","unstructured":"Horgan N, Shields CL, Mashayekhi A et al (2009) Periocular triamcinolone for prevention of macular edema after plaque radiotherapy of uveal melanoma: a randomized controlled trial. Ophthalmology 116(7):1383\u20131390. https:\/\/doi.org\/10.1016\/j.ophtha.2009.01.051","journal-title":"Ophthalmology"},{"issue":"1","key":"4132_CR75","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.ophtha.2013.08.039","volume":"121","author":"SU Shah","year":"2014","unstructured":"Shah SU, Shields CL, Bianciotto CG et al (2014) Intravitreal bevacizumab at 4-month intervals for prevention of macular edema after plaque radiotherapy of uveal melanoma. Ophthalmology 121(1):269\u2013275. https:\/\/doi.org\/10.1016\/j.ophtha.2013.08.039","journal-title":"Ophthalmology"},{"issue":"2","key":"4132_CR76","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1001\/jamaophthalmol.2019.5132","volume":"138","author":"CL Shields","year":"2020","unstructured":"Shields CL, Dalvin LA, Chang M et al (2020) Visual outcome at 4 years following plaque radiotherapy and prophylactic intravitreal bevacizumab (every 4 months for 2 years) for uveal melanoma: comparison with nonrandomized historical control individuals. JAMA Ophthalmol 138(2):136\u2013146. https:\/\/doi.org\/10.1001\/jamaophthalmol.2019.5132","journal-title":"JAMA Ophthalmol"},{"issue":"5","key":"4132_CR77","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.oret.2020.01.010","volume":"4","author":"BE Powell","year":"2020","unstructured":"Powell BE, Finger PT (2020) Anti-VEGF therapy immediately after plaque radiation therapy prevents or delays radiation maculopathy. Ophthalmol Retina 4(5):547\u2013550. https:\/\/doi.org\/10.1016\/j.oret.2020.01.010","journal-title":"Ophthalmol Retina"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-026-04132-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-026-04132-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-026-04132-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:14:44Z","timestamp":1785521684000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-026-04132-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4132"],"URL":"https:\/\/doi.org\/10.1007\/s10792-026-04132-5","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"assertion":[{"value":"9 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant financial or non-financial interest to disclose\n                      .","order":1,"name":"Ethics","label":"Conflict of intreset","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"315"}}